Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Cell Biology|October 17, 2025
Generation and functional evaluation of bispecific T cell engaging antibodiesAntonio Tapia-Galisteo, Rodrigo Lázaro-Gorines, Luis Álvarez-Vallina
International Journal of Molecular Sciences|October 16, 2025
An Innovative Immunotoxin Design Against Allergy Based on the IL-33 Cytokine and the Ribotoxin α-SarcinJavier Narbona, Rodrigo Lázaro-Gorines, Adrián Gutiérrez-Carmona, et al.
Toxins|October 17, 2019
Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based ImmunotoxinsJavier Ruiz-de-la-Herrán, Jaime Tomé-Amat, Rodrigo Lázaro-Gorines, et al.
Scientific Reports|July 25, 2020
Der p 1-based immunotoxin as potential tool for the treatment of dust mite respiratory allergyRodrigo Lázaro-Gorines, Juan Carlos López-Rodríguez, Sara Benedé, et al.
Toxicology and Applied Pharmacology|May 13, 2024
Pharmacokinetics and safety of LEAD-452, an EGFR-specific 4-1BB-agonistic trimerbody in non-human primatesRocío Navarro, Susana Frago, Oana Hangiu, et al.
Toxins|February 24, 2017
Fungal Ribotoxins: A Review of Potential Biotechnological ApplicationsMiriam Olombrada, Rodrigo Lázaro-Gorines, Juan C López-Rodríguez, et al.
Antibodies (Basel, Switzerland)|May 28, 2024
Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist ActivityLaura Rubio-Pérez, Susana Frago, Marta Compte, et al.
Iscience|September 8, 2022
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicityOana Hangiu, Marta Compte, Anders Dinesen, et al.
Oncoimmunology|April 28, 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor responseLaura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L Harwood, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 20, 2023
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo, et al.
Pageof 2